Welcome to LookChem.com Sign In|Join Free

Article Doi

Stuctural Studies on Bio-active Compounds. Part 5. Synthesis and Properties of 2,4-Diaminopyrimidine Dihydrofolate Reductase Inhibitors bearing Lipophilic Azido Groups

DOI: 10.1039/P19870002217

Source and publish data:

Journal of the Chemical Society. Perkin transactions I p. 2217 - 2228 (1987)

Update date:2022-09-26

Topics:

Authors:

Bliss, Edward A.Bliss, Edward A.

Griffin, Roger J.Griffin, Roger J.

Stevens, Malcolm F. G.Stevens, Malcolm F. G.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1039/P19870002217

A series of 2,4-diamino-5-(azidoaryl)-6-alkylpyrimidines has been prepared.The azide (36) (MZP) can be reduced by thiol reagents to the corresponding amine (28) but reductive deazidation occured when the series of azidophenyl derivatives was heated with hydrazine hydrate.Degradation of azide (36) in a trifluoroacetic acid-trifluoromethanesulphonic acid mixture at 0 deg C affords a means of introducing the bulky trifluoromethylsulphonyloxy substituent into the hindered ortho-position of the 5-aryl substituent.The products formed from thermolysis and photolysis of the azide (36) and the planar analogue 2,4-diamino-6-azidoquinazoline (70) derive from the triplet nitrene reactive intermediates. The azido compounds are potent inhibitors of rat liver dihydrofolate reductase although not as active as metoprin.The azide (36), as its ethanesulphonic acid salt, was selected for clinical trial on the basis of its ease of synthesis and suitable biological and pharmaceutical properties, and has a shorter biological half-life than compounds of comparable hydrophobicity.

View More

Products guided by the article

Product name:Benzeneacetonitrile, 3-chloro-a-(1-methoxypropylidene)-

Cas No:113494-30-7

113494-30-7

R&D Labs maybe for 113494-30-7

Relevant to this article

Hot Product